[P25-3] P25-3: Anti-infective drugs (3): TB drugs

[P25-3-6] Meta-analysis of NAT2 genotypes and the risk for anti-tuberculosis induced liver injury (AT-DILI)

Supharat Suvichapanich¹, Hilyataz Zahroh², Taisei Mushiroda³, Surakameth Mahasirimongkol⁴, Licht Toyo-Oka⁵, Usa Chaikledkaew⁶, Jiraphun Jittikoon⁷, Rika Yuliwulandari⁸, Hideki Yanai⁹, Sukanya Wattanapokayakit¹⁰, Katsushi Tokunaga¹¹ (1.University of Tokyo, 2.The University of Yarsi, 3.RIKEN Center for Integrative Medical Sciences, 4.Medical Genetics Center, Medical Life Sciences Institute, Ministry of Public Health, 5.University of Tokyo, 6.Mahidol University, 7.Mahidol University, 8.The University of Yarsi, 9.Fukujuji Hospital, Japan Anti Tuberculosis Association, 10.Medical Genetics Center, Medical Life Sciences Institute, Ministry of Public Health, 11.University of Tokyo)

Keywords:NAT2, anti-tuberculosis drug-induced liver injury, polymorphism, meta-analysis